Issue 39, 2023

Correction: Silver complexes with substituted terpyridines as promising anticancer metallodrugs and their crystal structure, photoluminescence, and DNA interactions

Abstract

Correction for ‘Silver complexes with substituted terpyridines as promising anticancer metallodrugs and their crystal structure, photoluminescence, and DNA interactions’ by Jiahe Li et al., Dalton Trans., 2023, 52, 9607–9621, https://doi.org/10.1039/D2DT03463H.

Associated articles

Article information

Article type
Correction
Submitted
21 Sep 2023
Accepted
21 Sep 2023
First published
02 Oct 2023
This article is Open Access
Creative Commons BY license

Dalton Trans., 2023,52, 14242-14242

Correction: Silver complexes with substituted terpyridines as promising anticancer metallodrugs and their crystal structure, photoluminescence, and DNA interactions

J. Li, Z. Wang, Z. Chen, X. Xue, K. Lin, H. Chen, L. Pan, Y. Yuan and Z. Ma, Dalton Trans., 2023, 52, 14242 DOI: 10.1039/D3DT90168H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements